The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen
Open accessAbstract
Background Filaggrin is important for skin barrier function and is mutated in 15-20% of patients with atopic dermatitis. Objective To examine whether filaggrin deficiency predisposes to skin inflammation and epicutaneous (EC) sensitization with protein antigen. Methods Skin histology in filaggrin-deficient ft/ft mice and WT controls was assessed by H&E staining and immunohistochemistry. Cytokine mRNA expression was examined by quantitative RT-PCR. Serum antibody levels and splenocyte secretion of cytokines were measured by ELISA. Results ft/ft mice developed eczematous skin lesions after age 28 weeks and a progressive increase in serum IgE and IgG1 levels. Normal appearing skin from 8-week-old ft/ft mice had epidermal thickening and increased dermal infiltration with CD4+ cells and expression of mRNA for IL-17, IL-6 and IL-23, but not IL-4, IL-13 or IFN-γ. Lesional skin of 32-week-old ft/ft mice exhibited qualitatively similar, but more pronounced, changes, and elevated IL-4 mRNA levels. EC application of ovalbumin (OVA) to shaved skin of 8-week-old ft/ft mice, but not WT mice, resulted in increased epidermal thickening, dermal infiltration by CD4+ cells, but not eosinophils, and expression of IL-17, IL-6, IL-23, IL-4 and IFN-γ, but not IL-5 or IL-13, mRNA. Splenocytes from EC sensitized ft/ft mice, but not controls, secreted cytokines in response to OVA stimulation and their sera, but not those of controls, contained OVA specific IgE and IgG1 antibodies. Conclusions Filaggrin deficient mice exhibit Th17-dominated skin inflammation, eczematous changes with age, and are permissive to EC sensitization with protein antigen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978
Moisturization and skin barrier function
Rawlings, A. V., & Harding, C. R. (2004) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2004.04s1005.x · Cited by 924
Seidenari, S., & Giusti, G. (1995) · Acta Dermato-Venereologica · doi:10.2340/0001555575429433 · Cited by 344
Cited by
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Boguniewicz, M., & Leung, D. Y. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01027.x · Cited by 1,073
Th2 Cytokines and Atopic Dermatitis
B. Brandt, E. (2011) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000110 · Cited by 655
One remarkable molecule: filaggrin
Brown, S. J., & Irwin McLean, W. H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.393 · Cited by 527
Early immune events in the induction of allergic contact dermatitis
Kaplan, D. H., Igyártó, B. Z., & Gaspari, A. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3150 · Cited by 521
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma
Zheng, T. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000202 · Cited by 497
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
Brown, S. J., Asai, Y., Cordell, H. J., Campbell, L. E., Zhao, Y., Liao, H., Northstone, K., Henderson, J., Alizadehfar, R., Ben-Shoshan, M., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.031 · Cited by 477
Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches
Leung, D. Y. M., & Guttman-Yassky, E. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.008 · Cited by 474
Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
Esaki, H., Brunner, P. M., Renert-Yuval, Y., Czarnowicki, T., Huynh, T., Tran, G., Lyon, S., Rodriguez, G., Immaneni, S., Johnson, D. B., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.013 · Cited by 428
The multifunctional role of filaggrin in allergic skin disease
McAleer, M. A., & Irvine, A. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.668 · Cited by 419
Significance of Skin Barrier Dysfunction in Atopic Dermatitis
Kim, B. E., & Leung, D. Y. M. (2018) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2018.10.3.207 · Cited by 393
IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors
Savinko, T., Matikainen, S., Saarialho-Kere, U., Lehto, M., Wang, G., Lehtimäki, S., Karisola, P., Reunala, T., Wolff, H., Lauerma, A., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.446 · Cited by 387
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
Liu, T., Li, S., Ying, S., Tang, S., Ding, Y., Li, Y., Qiao, J., & Fang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594735 · Cited by 386
Kabashima, K. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.02.001 · Cited by 361
Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization
Chang, H.-W., Yan, D., Singh, R., Liu, J., Lu, X., Ucmak, D., Lee, K., Afifi, L., Fadrosh, D., Leech, J., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0533-1 · Cited by 344
Kypriotou, M., Huber, M., & Hohl, D. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01472.x · Cited by 333
Recent insights into atopic dermatitis and implications for management of infectious complications
Boguniewicz, M., & Leung, D. Y. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.027 · Cited by 329
Skin Barrier Disruption: A Requirement for Allergen Sensitization?
De Benedetto, A., Kubo, A., & Beck, L. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.435 · Cited by 317
Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice
Kawasaki, H., Nagao, K., Kubo, A., Hata, T., Shimizu, A., Mizuno, H., Yamada, T., & Amagai, M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.068 · Cited by 301
Atopic dermatitis: the skin barrier and beyond
Tsakok, T., Woolf, R., Smith, C. H., Weidinger, S., & Flohr, C. (2019) · British Journal of Dermatology · doi:10.1111/bjd.16934 · Cited by 287
Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review
Ong, P. Y., & Leung, D. Y. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8548-5 · Cited by 281
Skin barrier defects in atopic dermatitis
Agrawal, R., & Woodfolk, J. A. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0433-9 · Cited by 201
Rerknimitr, P., Otsuka, A., Nakashima, C., & Kabashima, K. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0044-7 · Cited by 187
Animal models of skin disease for drug discovery
Avci, P., Sadasivam, M., Gupta, A., De Melo, W. C., Huang, Y.-Y., Yin, R., Chandran, R., Kumar, R., Otufowora, A., Nyame, T., et al. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.761202 · Cited by 130
“These findings indicated that flaky tail mice demonstrate Th17-dominated skin inflammation and eczematous dermatitis with advancing age change [56].”
BackgroundEpidermal Barrier in Atopic Dermatitis
Kim, B. E., & Leung, D. Y. (2012) · Allergy, Asthma and Immunology Research · doi:10.4168/aair.2012.4.1.12 · Cited by 114
“FLG deficiency alters the shape of corneocytes in the human skin,(12) and exhibits skin inflammation and enhances epicutaneous sensitization in murine models of eczema.(15) In addition, it has been shown that FLG deficiency confers a paracellular skin barrier abnormality that reduces inflammatory thresholds to irritan…”
BackgroundRezvani, H. R., Ali, N., Serrano-Sanchez, M., Dubus, P., Varon, C., Ged, C., Pain, C., Cario-André, M., Seneschal, J., Taïeb, A., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.082370 · Cited by 90
Archer, N. K., Jo, J.-H., Lee, S. K., Kim, D., Smith, B., Ortines, R. V., Wang, Y., Marchitto, M. C., Ravipati, A., Cai, S. S., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.042 · Cited by 82
Self-citationWhole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum
Bin, L., Malley, C., Taylor, P., Preethi Boorgula, M., Chavan, S., Daya, M., Mathias, M., Shankar, G., Rafaels, N., Vergara, C., et al. (2021) · Allergy · doi:10.1111/all.14762 · Cited by 33
Cutaneous Immune Cell-Microbiota Interactions Are Controlled by Epidermal JunB/AP-1
Uluçkan, Ö., Jiménez, M., Roediger, B., Schnabl, J., Díez-Córdova, L. T., Troulé, K., Weninger, W., & Wagner, E. F. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.042 · Cited by 21
Ahuja, S. K., Manoharan, M. S., Harper, N. L., Jimenez, F., Hobson, B. D., Martinez, H., Ingale, P., Liu, Y.-G., Carrillo, A., Lou, Z., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.019 · Cited by 18
“Additional studies in humans and mice support skin-barrier impairment as a crucial requirement for allergen sensitization.(4,12-18) In this emerging paradigm, resistance to the development of allergic diseases requires the generation of a balanced response to allergen challenge during early childhood that is dominated…”
Background
Metadata
- Authors
- Oyoshi, M. K., Murphy, G. F., & Geha, R. S.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 124
- Issue
- 3
- Pages
- 485-493.e1
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2158282912
- Cited by
- 245
- References
- 3
- FWCI
- 27.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.